Cargando…
How sepsis parallels and differs from COVID-19
Autores principales: | Herminghaus, Anna, Osuchowski, Marcin F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718536/ https://www.ncbi.nlm.nih.gov/pubmed/36470836 http://dx.doi.org/10.1016/j.ebiom.2022.104355 |
Ejemplares similares
-
Why does the sepsis induced by severe COVID-19 have different clinical features from sepsis induced by CrKP?
por: Lin, Hong-Yuan
Publicado: (2022) -
Immunotherapies for COVID-19: lessons learned from sepsis
por: Remy, Kenneth E, et al.
Publicado: (2020) -
COVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspective
por: Cavaillon, Jean-Marc, et al.
Publicado: (2021) -
Rethinking sepsis after a two-year battle with COVID-19
por: Zhang, Yingying, et al.
Publicado: (2022) -
Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19
por: Mu, Xiuying, et al.
Publicado: (2021)